EUVIMEDEUVIMED entdecken
Crossref

The Impact of Hospital Safety‐Net Burden Status on Patients with HPV‐Positive Oropharyngeal Cancer

Shivee Gilja iD, Arvind Kumar, Danielle Kapustin iD, Vivian Su iD, Samuel J Rubin, Raymond Chai, Scott A Roof iD, Mohemmed N Khan

The Laryngoscope · 2024

DOI: 10.1002/lary.31131 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Laryngoscope, 2024. Verfasst von Shivee Gilja und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology Head and Neck Surgery, Icahn School of Medicine at Mount Sina, New York, New York, USA. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Papillomavirus Infections, Oropharyngeal Neoplasms, Robotic Surgical Procedures. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The objective of this study was to compare treatment characteristics and outcomes between patients with HPV‐positive oropharyngeal squamous cell carcinoma (OPSCC) treated at hospitals of varying safety‐net burden status.

Methods

Patients with cT1‐4, N0‐3, M0 HPV‐positive OPSCC who underwent definitive surgery or radiation were included. Patients were grouped based on their treating hospital safety‐net burden status, defined as the percentage of uninsured and Medicaid‐insured patients with OPSCC treated at the facility and stratified as low burden (LBH: 0–25th percentile), medium burden (MBH: 25th–75th percentile), or high burden (HBH: 75th–100th percentile). The primary outcome was primary treatment with surgery versus radiation, evaluated with multivariable‐adjusted logistic regression. Secondary outcomes included TORS versus open surgical approach, and overall survival evaluated with Cox proportional hazards analysis.

Results

Of the 19,810 patients with cT1‐4, N0‐3, M0 HPV‐positive OPSCC included in this study, 4921 (24.8%) were treated at LBH, 12,201 (61.6%) were treated at MBH, and 2688 (13.6%) were treated at HBH. In multivariable‐adjusted analysis, compared with treatment at LBH, treatment at HBH was associated with more frequent radiation over surgical treatment (OR: 1.26, 95% CI: 1.12–1.40, p < 0.001). For patients undergoing surgery, patients at HBH had less frequent transoral robotic surgery (OR: 0.30, 95% CI 0.24–0.38, p < 0.001) compared with patients treated at LBH. Overall survival of patients treated at HBH was worse than that of patients treated at LBH (HR: 1.27, 95% CI 1.13–1.43, p < 0.001).

Conclusion

These findings highlight underlying disparities at higher safety‐net burden facilities that impact patterns of care and outcomes for patients with OPSCC. Level of Evidence 3 Laryngoscope , 134:1733–1740, 2024

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Squamous CellPapillomavirus InfectionsOropharyngeal NeoplasmsRobotic Surgical ProceduresHead and Neck NeoplasmsHumansSquamous Cell Carcinoma of Head and NeckHospitalsRetrospective Studies

Stichwörter der Autor:innen

disparitiesoropharyngeal squamous cell carcinomaoverall survivalpatterns of caresafety-net hospital

Autor:innen und Institutionen

  • Department of Otolaryngology Head and Neck Surgery, Icahn School of Medicine at Mount Sina, New York, New York, USA.

ORCID-Profile: Shivee Gilja, Danielle Kapustin, Vivian Su, Scott A Roof

Zitieren

APA

Gilja, S., Kumar, A., Kapustin, D., Su, V., Rubin, S. J., Chai, R., Roof, S. A., & Khan, M. N. (2024). The Impact of Hospital Safety‐Net Burden Status on Patients with HPV‐Positive Oropharyngeal Cancer. The Laryngoscope. https://doi.org/10.1002/lary.31131

Vancouver

Gilja S, Kumar A, Kapustin D, Su V, Rubin SJ, Chai R, et al. The Impact of Hospital Safety‐Net Burden Status on Patients with HPV‐Positive Oropharyngeal Cancer. The Laryngoscope. 2024. doi:10.1002/lary.31131

BibTeX
@article{Gilja2024,
  author = {Gilja, Shivee and Kumar, Arvind and Kapustin, Danielle and Su, Vivian and Rubin, Samuel J and Chai, Raymond and Roof, Scott A and Khan, Mohemmed N},
  title = {The Impact of Hospital Safety‐Net Burden Status on Patients with HPV‐Positive Oropharyngeal Cancer},
  journal = {The Laryngoscope},
  year = {2024},
  doi = {10.1002/lary.31131}
}
Kostenlos starten →